Results 1 to 10 of about 23,287 (168)

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier [PDF]

Clinical Case Reports, 2022
This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers.
Takatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, Saori Amiya, Yuichi Adachi, Takayuki Niitsu, Yoshimi Noda, Reina Hara, Kiyoharu Fukushima, Yasuhiko Suga, Kotaro Miyake, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Natsuko Tokuhira, Akinori Uchiyama, Yoshito Takeda, Atsushi Kumanogoh   +17 more
doaj   +6 more sources

Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1 [PDF]

Annals of Thoracic Medicine, 2020
Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorders (HABAs) are pulmonary disorders with various interstitial lung disease patterns that often occur in HTLV-1 carriers.
Masahiro Yamasaki, Masaya Taniwaki, Kunihiko Funaishi, Noboru Hattori   +3 more
doaj   +4 more sources

Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type-1 Transmission [PDF]

Emerging Infectious Diseases, 2019
We report human T-cell lymphotropic virus type 1 infection associated with self-flagellation in 10 UK residents. These persons were heterosexual men from Pakistan, India, and Iraq.
Alice R. Tang, Graham P. Taylor, Divya Dhasmana   +2 more
doaj   +5 more sources

High proviral load of human T cell lymphotropic virus type-1 facilitates coronary artery diseases [PDF]

Iranian Journal of Basic Medical Sciences, 2020
Objective(s): Coronary artery disease (CAD) is known as a life threatening disease, worldwide. In this study the role of HTLV-1 infection was evaluated on cardiac involvement in an endemic region of northeastern Iran.Materials and Methods: Serologic and ...
Farnaz Mozayeni, Seyed Abdolrahim Rezaee, Farahnaz Jabbari Azad, Mahmoud Shabestari, Reza Faridhosseini, Houshang Rafatpanah, Hadis Yousefzadeh, Yousef Ali Garivani, Lida Jarahi, Narges Valizadeh, Faezah Sabet, Sharare Moshirahmadi, Fatemeh Sadat Mohammadi, Mohammad Shabestari   +13 more
doaj   +2 more sources

Seroprevalence and molecular detection of human t-cell lymphotropic virus type 1 among multi –transfused patients in Sana’a City, Yemen [PDF]

BMC Infectious Diseases
Background The prevalence of Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) represents a major public health challenge, threatening the safety of blood transfusions for patients globally, particularly in Yemen due to the lack of routine pre-transfusion ...
Yasser Ghaleb, Arwa Mohammed Othman, Rowa M. Assayaghi   +2 more
doaj   +2 more sources

Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation [PDF]

Infectious Agents and Cancer
Introduction Human T-cell Lymphotropic virus type 1 (HTLV-1) belongs to retroviridae which is connected to two major diseases, including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and Adult T-cell leukemia/lymphoma (ATLL).
Arash Letafati, Atefeh Bahavar, Alijan Tabarraei, Mehdi Norouzi, Abdollah Amiri, Sayed-Hamidreza Mozhgani   +5 more
doaj   +2 more sources

Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1). [PDF]

PLoS Neglected Tropical Diseases, 2018
BACKGROUND:HTLV-1 infection is endemic in Brazil. About 1 to 2% of the Brazilian population is estimated to be infected, but most infected HTLV-1 individuals do not know about their own infection, which favors the continuity of sexual and vertical virus ...
Luiz C F Romanelli, Débora M Miranda, Anna B F Carneiro-Proietti, Marcelo Mamede, Herika M M Vasconcelos, Marina L Martins, Anísia S D Ferreira, Daniela V F Rosa, Jonas J Paula, Marco A Romano-Silva, Rodrigo Nicolato   +10 more
doaj   +2 more sources

Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1) [PDF]

Brazilian Journal of Infectious Diseases, 2017
Introduction: Despite the high prevalence of chronic pain in individuals infected with HTLV-1, predictive and protective factors for its development are still unclear. Objective: To identify factors associated with chronic pain in individuals with HTLV-1.
Dislene N. dos Santos, Kionna O.B. Santos, Alaí B. Paixão, Rosana Cristina P. de Andrade, Davi T. Costa, Daniel L. S-Martin, Katia N. Sá, Abrahão F. Baptista   +7 more
doaj   +2 more sources

HTLV-1 and Co-infections

Frontiers in Medicine, 2022
Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell infection in humans, impacting the host immune response. This virus causes a range of clinical manifestations, from inflammatory conditions, including neuronal damage (
Carolina Rosadas, Graham P. Taylor, Graham P. Taylor   +2 more
doaj   +1 more source

Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures

Nature Communications, 2021
Human T-cell lymphotropic virus type 1 (HTLV-1) is an oncogenic deltaretrovirus. Here the authors provide structural characterization of the binding mechanism of novel integrase strand transfer inhibitor (INSTI) candidates to limit HTLV-1 infection.
Michal S. Barski, Teresa Vanzo, Xue Zhi Zhao, Steven J. Smith, Allison Ballandras-Colas, Nora B. Cronin, Valerie E. Pye, Stephen H. Hughes, Terrence R. Burke, Peter Cherepanov, Goedele N. Maertens   +10 more
doaj   +1 more source